Author:
D’Ercole C.,Ivorra D.,Levy-Mozzigonacci A.,Haumonte J. B.,Shojai R.,Chau C.,Puppo S.,Toga C.,Bretelle F.,Boubli L.
Reference29 articles.
1. Haddow JE, Palomaki GE, Knight GI, et al. (1992) Prenatal screening for Down’s syndrome with use of maternal serum markers. N Engl J Med 327: 588–593
2. Phillips OP, Elias S, Shulman LP, et al. (1992). Maternal serum screening for fetal Down’s syndrome in women less than 35 years of age using alpha-foetoprotein, hCG, and unconjugated oestriol: a prospective 2-year study. Obstet Gynecol 80: 353–358
3. Snijders RJM, Johnson S, Sebire NJ, et al. (1996) First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 7: 216–226
4. Wald NJ, Kennard A, Densem JW, et al. (1992). Antenal maternal serum screening for Down’s syndrome: results of a demonstration project. Br Med J 305: 291–294
5. Pandya PP, Snijders RJM, Johnson, et al. (1995) Screening for fetaltrisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 102: 957–962